Effects of Antenatal Antibiotics on the Incidence and Bacteriological Profile of Early-Onset Neonatal Sepsis
- 1 July 2003
- journal article
- Published by S. Karger AG in Neonatology
- Vol. 84 (1) , 24-30
- https://doi.org/10.1159/000071439
Abstract
Background: Recommendations for the use of antenatal antibiotics have been widely implemented in the past few years, notably to prevent group B streptococcal disease or to prolong pregnancy in the case of preterm premature rupture of the membranes. Objectives: We designed a retrospective study to assess the potential effects of this increasing use of antibiotics on the incidence and bacteriological profile of early-onset neonatal sepsis (EONS). Methods: All neonates referred to our department for suspected EONS from January 1 1995 through December 31 1999 were included. Antenatal antibiotic exposure together with clinical and microbiological data from the neonatal period were gathered and analyzed on a yearly basis. Results: Of the 485 newborns who met the inclusion criteria, there were 101 cases of culture-confirmed sepsis; 339 cases of suspected sepsis and 69 cases of confirmed sepsis involved children born in the hospital, among a total of 16,627 live births registered in our center over the study period. The overall incidence of EONS dropped from 6.8 to 0.6/1,000 births between 1995 and 1999 (p < 0.001), but the rate of group B streptococcal infection decreased much more rapidly than that of non-group B streptococcal infection. We observed a trend towards the emergence of ampicillin-resistant Escherichia coli strains, which were isolated in seven cases. Among E. coli infections, ampicillin resistance was statistically linked with antenatal antibiotic use (p = 0.025). We also delineated several risk factors associated with these infections. Conclusion: In our center, antenatal antibiotic treatment was effective in reducing the incidence of EONS, but this benefit may come at the cost of favoring the emergence of ampicillin-resistant organisms causing severe neonatal infections. Antenatal and postnatal antibiotic treatment strategies should take this adverse effect into account.Keywords
This publication has 9 references indexed in Scilit:
- Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 2002
- No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organismsAmerican Journal of Obstetrics and Gynecology, 2001
- Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trialThe Lancet, 2001
- Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trialThe Lancet, 2001
- Group B Streptococcal Disease in the Era of Intrapartum Antibiotic ProphylaxisNew England Journal of Medicine, 2000
- Neonatal Escherichia coli infections: concerns regarding resistance to current therapyActa Paediatrica, 2000
- Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsisInfectious Diseases in Obstetrics and Gynecology, 1999
- Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units NetworkJAMA, 1997
- Revised Guidelines for Prevention of Early-onset Group B Streptococcal (GBS) InfectionPediatrics, 1997